CDC Health Advisory about Antibiotic Resistant Strains of Serogroup Y Meningococcus

Published: 06/18/2020

  • Centers for Disease Control and Prevention
Relevant To:
  • Ambulatory Surgical Centers,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Clinical Lab,
  • Pharmacy,
  • Rural Health Clinics

The U.S. Centers for Disease Control and Prevention (CDC) has issued a Health Advisory to communicate important information about the detection of Ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis serogroup Y isolates in the United States. While resistance to the antibiotics used for meningococcal treatment and prophylaxis, including penicillin and ciprofloxacin, has been rare in the United States, recently penicillin- and ciprofloxacin-resistant N. meningitidis serogroup Y (

Sign Up for Free Trial